Brigatinib Nitroso Impurity 2
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Brigatinib is used to treat a certain type of non-small cell lung cancer (NSCLC) that has spread to other parts of the bodys. Brigatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein that signals cancer cells to multiply.Brigatinib Nitroso Impurity 2is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Brigatinib Nitroso Impurity 2 CAS NO:NA chemically represented as N-(5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)-N-(2-(dimethylphosphoryl) phenyl)nitrous amide . Synchemia is the leading manufacturing and exporter of Brigatinib Nitroso Impurity 2 . We supply Brigatinib Nitroso Impurity 2 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141523 |
| CAS No | NA |
| Mol.F. | C16H16ClFN4O2 |
| Mol.Wt. | 350.8 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141524 |
| CAS No | 59467-62-8 |
| Mol.F. | C16H12ClFN4O |
| Mol.Wt. | 330.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141525 |
| CAS No | NA |
| Mol.F. | C16H12ClFN4O2 |
| Mol.Wt. | 346.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141526 |
| CAS No | NA |
| Mol.F. | C16H10ClFN4O4 |
| Mol.Wt. | 376.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141527 |
| CAS No | NA |
| Mol.F. | C18H20N2O2 |
| Mol.Wt. | 296.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141528 |
| CAS No | NA |
| Mol.F. | C8H8N8O2 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141529 |
| CAS No | NA |
| Mol.F. | C14H17N7O2 |
| Mol.Wt. | 315.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141530 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141531 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141532 |
| CAS No | NA |
| Mol.F. | C10H11ClN2O2 |
| Mol.Wt. | 226.66 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141533 |
| CAS No | NA |
| Mol.F. | C13H19N3O2 |
| Mol.Wt. | 249.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141534 |
| CAS No | NA |
| Mol.F. | C12H17N3O2 |
| Mol.Wt. | 235.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141535 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141536 |
| CAS No | NA |
| Mol.F. | C28H33N3O3 |
| Mol.Wt. | 459.6 |
| INV STATUS | In Stock |
| CAT No | SRC-N0141537 |
| CAS No | NA |
| Mol.F. | C30H37N3O3 |
| Mol.Wt. | 487.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141538 |
| CAS No | NA |
| Mol.F. | C26H22FIN6O5 |
| Mol.Wt. | 644.7 |
| INV STATUS | CUSTOM SYNTHESIS |